Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Liposome (VS-1024-FY60)

CAT#: VS-1024-FY60

The application of anti-BRCA1 antibody-conjugated liposomes in the treatment of breast cancer is currently under investigation. This approach helps in targeted therapy, particularly in cases with BRCA mutations, and can enhance the specificity and efficacy of the drugs. However, the specific clinical applications and efficacy need further research and validation.

Gene Expression
Figure 1 IF staining of human cell line RH-30 Figure 2 IHC staining of human testis Figure 3 Cerebral cortex Figure 4 Colon Figure 5 Testis Figure 6 Skin Figure 7 Lymph node Figure 8 RNA cell line category: Low cell line specificity
Sub Cat Product Name Liposome Name Datasheet  
VS-1124-FY1004 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled PEGylated Liposome (VS-1124-FY1004) PEGylated liposome
VS-1124-FY1005 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Triptolide-loaded Liposome (VS-1124-FY1005) Triptolide-loaded liposome
VS-1124-FY1006 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Gd-SLs Liposome (VS-1124-FY1006) Gd-SLs liposome
VS-1124-FY1007 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Phospholipid Liposome (VS-1124-FY1007) Phospholipid liposome
VS-1124-FY1008 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Cationic Liposome (VS-1124-FY1008) Cationic liposome
VS-1124-FY1009 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Adriamycin-encapsulated Liposome (VS-1124-FY1009) Adriamycin-encapsulated liposome
VS-1124-FY1010 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Magnetofluorescent Liposome (VS-1124-FY1010) Magnetofluorescent liposome
VS-1124-FY1011 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled pH-sensitive Liposome (VS-1124-FY1011) pH-sensitive liposome
VS-1124-FY1012 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Phototoxic Liposome (VS-1124-FY1012) Phototoxic liposome
VS-1124-FY1013 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Targeted Liposome (VS-1124-FY1013) Targeted Liposome
VS-1124-FY1014 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Apt1-Liposome (VS-1124-FY1014) Apt1-liposome
VS-1124-FY1015 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Thermosensitive Liposome (VS-1124-FY1015) Thermosensitive liposome
VS-1124-FY1016 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Clodronate Liposome (VS-1124-FY1016) Clodronate liposome
VS-1124-FY1017 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Galcer Liposome (VS-1124-FY1017) Galcer liposome
VS-1124-FY1018 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled HBsAg-loaded Liposome (VS-1124-FY1018) HBsAg-loaded liposome
VS-1124-FY1019 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled Phospholipid Liposome and Cationic Liposome (VS-1124-FY1019) Phospholipid liposome and Cationic liposome
VS-1124-FY1020 Anti-BRCA1 (clone W24V57) Recombinant Antibody Coupled ISMN Liposome (VS-1124-FY1020) ISMN liposome
More Infomation

Specifications

  • Potential Clinical Applications
  • Breast cancer

Product Composition

  • Clone
  • W24V57
  • Antibody Type
  • IgG
  • Antibody Host
  • Mouse
  • Antibody Reactivity
  • Human
  • Antibody Description
  • This product is a recombinant antibody derived from mouse sources, specifically designed to recognize and bind to the BRCA1 protein. BRCA1, or Breast Cancer 1, is a crucial gene associated with DNA repair mechanisms and is well-known for its role in breast and ovarian cancer susceptibility. The recombinant nature of this antibody ensures high specificity and affinity towards the BRCA1 protein, making it an invaluable tool for various research applications, including cancer study, gene function analysis, and therapeutic research. Utilizing this antibody can enhance the understanding of BRCA1's biological functions and its implications in oncogenesis, ultimately contributing to more targeted treatments and diagnostic approaches in cancer therapy.

Product Property

  • Storage
  • See in the COA
  • Storage Shelf Time
  • See in the COA

Target Information

  • Target
  • BRCA1
  • Introduction
  • This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified.
  • Alternative Names
  • IRIS; PSCP; BRCAI; BRCC1; FANCS; PNCA4; RNF53; BROVCA1; PPP1R53
  • Full Name
  • BRCA1, DNA Repair Associated
  • Cellular Localization
  • Nucleus, Chromosome, Cytoplasm
  • Post Translation Modifications
  • Glycosylation at Asn247 ( NX_P38398 [NX_P38398-1] )
    Ubiquitination at Lys987 ( NX_P38398 [NX_P38398-1] )
    Modification sites at PhosphoSitePlus ( P38398 )
    Glycosylation from GlyConnect BRCA1_HUMAN (2024)
    Glycosylation from GlyGen (P38398) 3 sites, 3 N-linked glycans (2 sites), 1 O-linked glycan (1 site)
  • Function
  • E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage (PubMed:10500182, 12887909, 12890688, 14976165, 16818604, 17525340, 19261748).
    It is unclear whether it also mediates the formation of other types of polyubiquitin chains (PubMed:12890688).
    The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability (PubMed:12890688, 14976165, 20351172).
    Regulates centrosomal microtubule nucleation.
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for VS-1024-FY60. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "BRCA1"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
BRD-0071MZ Chicken Anti-BRCA1 Polyclonal IgY WB Chicken antibody

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare